APS Support UK
Sign up for e-news»   Donate now»   Join us »

The Centre for Rheumatology at University College London has been awarded a £3.5 million grant from the Medical Research Council to continue developing a new treatment for antiphospholipid syndrome (APS), the largest grant ever awarded in the UK for research into APS.

The grant will support the next three years' work on the project designed to develop the new agent to the point where trials in humans could start.

Professor Anisur Rahman, a Trustee and Medical Advisor to APS Support UK, is leading the team at UCL who are working in partnership with Abzena, a biotechnology company that provides specialist chemical technology needed to develop this potential treatment.

About APS
What is it?
How is it diagnosed?
How is it treated?
What are the symptoms?
Self Help
Newly diagnosed
FAQs
Fact sheets
Patient stories
Get Involved
Join our charity
Visit our shop
Help us fundraise
Make a donation
About Us
What we do
APS in the news
Media enquiries
Contact us
Follow Us
Big Lottery Fund

© 2017 APS Support UK (trading name of the Hughes Syndrome Foundation). Registered Charity Number 1138116. A company limited by guarantee registered in England 7268671.